KMT2C and urinary bladder carcinoma: Although previous findings have shown that KMT2C is a promising target for the treatment of cervical and bladder cancers, the specific molecular mechanisms involved in the regulation of KMT2C in cervical and bladder cancers remain to be further investigated.